Select Medical Corporation
SEM | NYSE
$16.51
-$0.01 (-0.09%)
At close: Jun 30, 2026, 4:02 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 5.45B | 5.19B | 6.66B | 6.33B | 6.2B | 5.53B |
Cost of Revenue | 4.82B | 4.55B | 5.73B | 5.6B | 5.29B | 4.71B |
Gross Profit | 629.3M | 633.64M | 932.04M | 733.38M | 919.37M | 821.34M |
Operating Income | 334.58M | 268.32M | 554.87M | 403.28M | 713.77M | 567.66M |
Interest Income | n/a | n/a | n/a | n/a | 5.35M | n/a |
Pretax Income | 272.75M | 174.77M | 382.36M | 260.58M | 629.72M | 456.47M |
Net Income | 146.22M | 214.04M | 243.49M | 158.99M | 402.23M | 259M |
Selling & General & Admin | 154.41M | 225.87M | 170.19M | 153.04M | 146.98M | 138.04M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 140.3M | 139.46M | 206.97M | 177.06M | 58.62M | 115.65M |
Operating Expenses | 294.72M | 365.33M | 377.17M | 330.09M | 205.59M | 253.68M |
Interest Expense | 117.58M | 128.61M | 198.64M | 169.11M | 135.99M | 153.01M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.12B | 4.92B | 6.11B | 5.93B | 5.49B | 4.96B |
Income Tax Expense | 58.22M | 44.78M | 82.63M | 62.55M | 129.77M | 111.87M |
Shares Outstanding (Basic) | 123.51M | 124.61M | 123.11M | 124.63M | 130.25M | 129.78M |
Shares Outstanding (Diluted) | 123.51M | 124.61M | 123.11M | 124.63M | 130.25M | 129.78M |
EPS (Basic) | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 | 1.93 |
EPS (Diluted) | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 | 1.93 |
EBITDA | 530.64M | 507.27M | 789.74M | 635.52M | 968.35M | 683.3M |
EBIT | 390.33M | 303.37M | 581M | 429.69M | 765.71M | 477.65M |
Depreciation & Amortization | 140.3M | 203.89M | 208.74M | 205.83M | 202.65M | 205.66M |
Add to Watchlist
Select watchlists to add or remove SEM